{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T21:27:53Z","timestamp":1772659673122,"version":"3.50.1"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1007493","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T00:00:00Z","timestamp":1575244800000}}],"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T00:00:00Z","timestamp":1574035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1007493","type":"journal-article","created":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T13:40:31Z","timestamp":1574084431000},"page":"e1007493","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":41,"title":["Contrasting the impact of cytotoxic and cytostatic drug therapies on tumour progression"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2102-1930","authenticated-orcid":true,"given":"Jani V.","family":"Anttila","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0677-6761","authenticated-orcid":true,"given":"Mikhail","family":"Shubin","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1329-2025","authenticated-orcid":true,"given":"Johannes","family":"Cairns","sequence":"additional","affiliation":[]},{"given":"Florian","family":"Borse","sequence":"additional","affiliation":[]},{"given":"Qingli","family":"Guo","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3603-0813","authenticated-orcid":true,"given":"Tommi","family":"Mononen","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0427-2639","authenticated-orcid":true,"given":"Ignacio","family":"V\u00e1zquez-Garc\u00eda","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5739-6278","authenticated-orcid":true,"given":"Otto","family":"Pulkkinen","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7270-1792","authenticated-orcid":true,"given":"Ville","family":"Mustonen","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2019,11,18]]},"reference":[{"key":"pcbi.1007493.ref001","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1126\/science.959840","article-title":"The clonal evolution of tumor cell populations","volume":"194","author":"PC Nowell","year":"1976","journal-title":"Science"},{"issue":"1","key":"pcbi.1007493.ref002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bjc.1954.1","article-title":"The age distribution of cancer and a multi-stage theory of carcinogenesis","volume":"8","author":"P Armitage","year":"1954","journal-title":"British Journal of Cancer"},{"issue":"9","key":"pcbi.1007493.ref003","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM198809013190901","article-title":"Genetic alterations during colorectal-tumor development","volume":"319","author":"B Vogelstein","year":"1988","journal-title":"The New England journal of medicine"},{"issue":"5","key":"pcbi.1007493.ref004","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.cell.2017.09.042","article-title":"Universal patterns of selection in cancer and somatic tissues","volume":"171","author":"I Martincorena","year":"2017","journal-title":"Cell"},{"issue":"5","key":"pcbi.1007493.ref005","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"D Hanahan","year":"2011","journal-title":"Cell"},{"key":"pcbi.1007493.ref006","article-title":"The evolutionary history of 2,658 cancers","author":"M Gerstung","year":"2018","journal-title":"bioRxiv"},{"key":"pcbi.1007493.ref007","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/ng.3489","article-title":"Identification of neutral tumor evolution across cancer types","volume":"48","author":"MJ Williams","year":"2016","journal-title":"Nature Genetics"},{"key":"pcbi.1007493.ref008","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fonc.2016.00152","article-title":"Metabolic imaging to assess treatment response to cytotoxic and cytostatic agents","volume":"6","author":"NJ Serkova","year":"2016","journal-title":"Frontiers in Oncology"},{"issue":"24","key":"pcbi.1007493.ref009","doi-asserted-by":"crossref","first-page":"7280","DOI":"10.1158\/1078-0432.CCR-07-2141","article-title":"Is cell death a critical end point for anticancer therapies","volume":"13","author":"O Rixe","year":"2007","journal-title":"Clinical Cancer Research"},{"key":"pcbi.1007493.ref010","doi-asserted-by":"crossref","first-page":"108103","DOI":"10.1103\/PhysRevLett.119.108103","article-title":"Bet hedging against demographic fluctuations","volume":"119","author":"B Xue","year":"2017","journal-title":"Physical Review Letters"},{"key":"pcbi.1007493.ref011","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nature14971","article-title":"A spatial model predicts that dispersal and cell turnover limit intratumour heterogeneity","volume":"525","author":"B Waclaw","year":"2015","journal-title":"Nature"},{"issue":"2","key":"pcbi.1007493.ref012","doi-asserted-by":"crossref","first-page":"e1004731","DOI":"10.1371\/journal.pcbi.1004731","article-title":"Quantifying clonal and subclonal passenger mutations in cancer evolution","volume":"12","author":"I Bo\u017ei\u0107","year":"2016","journal-title":"PLoS Computational Biology"},{"issue":"1","key":"pcbi.1007493.ref013","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.trecan.2015.11.003","article-title":"Cancer evolution and the limits of predictability in precision cancer medicine","volume":"2","author":"KA Lipinski","year":"2016","journal-title":"Trends in Cancer"},{"key":"pcbi.1007493.ref014","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1126\/science.aaf2784","article-title":"Metastasis as an evolutionary process","volume":"352","author":"S Turajlic","year":"2016","journal-title":"Science"},{"issue":"27","key":"pcbi.1007493.ref015","doi-asserted-by":"crossref","first-page":"9714","DOI":"10.1073\/pnas.0501870102","article-title":"Drug resistance in cancer: Principles of emergence and prevention","volume":"102","author":"NL Komarova","year":"2005","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"10","key":"pcbi.1007493.ref016","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nrmicro1477","article-title":"Bioinformatics-assisted anti-HIV therapy","volume":"4","author":"T Lengauer","year":"2006","journal-title":"Nature Reviews Microbiology"},{"key":"pcbi.1007493.ref017","doi-asserted-by":"crossref","first-page":"e00747","DOI":"10.7554\/eLife.00747","article-title":"Evolutionary dynamics of cancer in response to targeted combination therapy","volume":"2","author":"I Bo\u017ei\u0107","year":"2013","journal-title":"eLife"},{"key":"pcbi.1007493.ref018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11538-014-0046-4","article-title":"Modeling the effects of space structure and combination therapies on phenotypic heterogeneity and drug resistance in solid tumors","volume":"77","author":"A Lorz","year":"2015","journal-title":"Bulletin of Mathematical Biology"},{"key":"pcbi.1007493.ref019","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1007\/s11538-017-0359-1","article-title":"Modeling the dynamics of heterogeneity of solid tumors in response to chemotherapy","volume":"79","author":"H Cho","year":"2017","journal-title":"Bulletin of Mathematical Biology"},{"issue":"11","key":"pcbi.1007493.ref020","doi-asserted-by":"crossref","first-page":"e1000557","DOI":"10.1371\/journal.pcbi.1000557","article-title":"Evolution of resistance to targeted anti-cancer therapies during continuous and pulsed administration strategies","volume":"5","author":"J Foo","year":"2009","journal-title":"PLoS Computational Biology"},{"key":"pcbi.1007493.ref021","doi-asserted-by":"crossref","first-page":"10871","DOI":"10.1073\/pnas.1100299108","article-title":"The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy","volume":"108","author":"AF Read","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"11","key":"pcbi.1007493.ref022","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1158\/0008-5472.CAN-08-3658","article-title":"Adaptive therapy","volume":"69","author":"RA Gatenby","year":"2009","journal-title":"Cancer Research"},{"issue":"2","key":"pcbi.1007493.ref023","doi-asserted-by":"crossref","first-page":"e2001110","DOI":"10.1371\/journal.pbio.2001110","article-title":"How to use a chemotherapeutic agents when resistance to it threatens the patient","volume":"15","author":"E Hansen","year":"2017","journal-title":"PLoS Biology"},{"issue":"4","key":"pcbi.1007493.ref024","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1073\/pnas.1409403112","article-title":"The value of monitoring to control evolving populations","volume":"112","author":"A Fischer","year":"2015","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"7046","key":"pcbi.1007493.ref025","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/nature03669","article-title":"Dynamics of chronic myeloid leukaemia","volume":"435","author":"F Michor","year":"2005","journal-title":"Nature"},{"issue":"1","key":"pcbi.1007493.ref026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-01968-5","article-title":"Integrating evolutionary dynamics into treatment of metastatic castrate-resistant prostate cancer","volume":"8","author":"J Zhang","year":"2017","journal-title":"Nature Communications"},{"key":"pcbi.1007493.ref027","article-title":"Emergent multicellular life cycles in filamentous bacteria owing to density-dependent population dynamics","author":"V Rossetti","year":"2011","journal-title":"Journal of The Royal Society Interface"},{"issue":"17","key":"pcbi.1007493.ref028","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nrc.2017.69","article-title":"Classifying the evolutionary and ecological features of neoplasms","volume":"10","author":"CC Maley","year":"2017","journal-title":"Nature Reviews Cancer"},{"issue":"4","key":"pcbi.1007493.ref029","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1073\/pnas.1420297111","article-title":"Opinion: Control vs. eradication: Applying infectious disease treatment strategies to cancer","volume":"112","author":"G Jansen","year":"2015","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"pcbi.1007493.ref030","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2174\/1568009023333872","article-title":"Examining the relationship between cancer invasion\/metastasis and drug resistance","volume":"2","author":"Y Liang","year":"2002","journal-title":"Current Cancer Drug Targets"},{"key":"pcbi.1007493.ref031","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.tree.2010.07.009","article-title":"Stochastic models of population extinction","volume":"25","author":"O Ovaskainen","year":"2010","journal-title":"Trends in Ecology and Evolution"},{"issue":"5","key":"pcbi.1007493.ref032","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.cell.2014.07.013","article-title":"Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis","volume":"158","author":"N Aceto","year":"2014","journal-title":"Cell"},{"key":"pcbi.1007493.ref033","doi-asserted-by":"crossref","first-page":"e1675","DOI":"10.1038\/cddis.2015.20","article-title":"How cell death shapes cancer","volume":"6","author":"V Labi","year":"2015","journal-title":"Cell Death and Disease"},{"issue":"43","key":"pcbi.1007493.ref034","doi-asserted-by":"crossref","first-page":"18545","DOI":"10.1073\/pnas.1010978107","article-title":"Accumulation of driver and passenger mutations during tumor progression","volume":"107","author":"I Bo\u017ei\u0107","year":"2010","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"11","key":"pcbi.1007493.ref035","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1073\/pnas.0712345105","article-title":"Comparative lesion sequencing provides insights into tumor evolution","volume":"105","author":"S Jones","year":"2008","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"pcbi.1007493.ref036","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature11219","article-title":"The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers","volume":"486","author":"LAJ Diaz","year":"2012","journal-title":"Nature"},{"key":"pcbi.1007493.ref037","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/02841868909111193","article-title":"Tumor cell proliferation kinetics and tumor growth rate","volume":"28","author":"M Tubiana","year":"1989","journal-title":"Acta Oncologica"},{"issue":"24","key":"pcbi.1007493.ref038","doi-asserted-by":"crossref","first-page":"7271","DOI":"10.1158\/1078-0432.CCR-07-1595","article-title":"The roles of therapy-induced autophagy and necrosis in cancer treatment","volume":"13","author":"RK Amaravadi","year":"2007","journal-title":"Clinical Cancer Research"},{"key":"pcbi.1007493.ref039","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: Molecular mechanisms of action","volume":"740","author":"PB Dasari S and Tchounwou","year":"2014","journal-title":"European Journal of Pharmacology"},{"key":"pcbi.1007493.ref040","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1470-2045(02)00676-9","article-title":"Trastuzumab: hopes and realities","volume":"3","author":"B Leyland-Jones","year":"2002","journal-title":"The Lancet Oncology"},{"issue":"20","key":"pcbi.1007493.ref041","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1200\/JCO.2009.25.4011","article-title":"Emerging targeted therapies for breast cancer","volume":"28","author":"RH Alvarez","year":"2010","journal-title":"Journal of Clinical Oncology"},{"issue":"11","key":"pcbi.1007493.ref042","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1021\/acschembio.6b00538","article-title":"Understanding cytotoxicity and cytostaticity in a high-throughput screening collection","volume":"11","author":"LH Mervin","year":"2016","journal-title":"ACS Chemical Biology"},{"issue":"3","key":"pcbi.1007493.ref043","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cmet.2014.01.001","article-title":"Rapamycin: One Drug, Many Effects","volume":"19","author":"J Li","year":"2014","journal-title":"Cell Metabolism"},{"issue":"2","key":"pcbi.1007493.ref044","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis","volume":"358","author":"JJ Bissler","year":"2008","journal-title":"New England Journal of Medicine"},{"key":"pcbi.1007493.ref045","doi-asserted-by":"crossref","first-page":"e32976","DOI":"10.7554\/eLife.32976","article-title":"Antibiotic-induced population fluctuations and stochastic clearance of bacteria","volume":"7","author":"J Coates","year":"2018","journal-title":"eLife"},{"issue":"27","key":"pcbi.1007493.ref046","doi-asserted-by":"crossref","first-page":"8173","DOI":"10.1073\/pnas.1509743112","article-title":"Antibiotic efficacy is linked to bacterial cellular respiration","volume":"112","author":"DJ Dwyer","year":"2015","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"8","key":"pcbi.1007493.ref047","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1128\/AAC.02463-14","article-title":"Antagonism between bacteriostatic and bactericidal antibiotics is prevalent","volume":"58","author":"PS Ocampo","year":"2014","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"2","key":"pcbi.1007493.ref048","doi-asserted-by":"crossref","first-page":"e89904","DOI":"10.1172\/jci.insight.89904","article-title":"Leukemia cell proliferation and death in chronic lymphocytic leukemia patients on therapy with the BTK inhibitor ibrutinib","volume":"2","author":"JA Burger","year":"2017","journal-title":"JCI Insight"},{"issue":"22","key":"pcbi.1007493.ref049","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1093\/bioinformatics\/btl465","article-title":"Dynamic partitioning for hybrid simulation of the bistable HIV-1 transactivation network","volume":"22","author":"M Griffith","year":"2006","journal-title":"Bioinformatics"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1007493","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T00:00:00Z","timestamp":1575244800000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1007493","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T14:23:09Z","timestamp":1575296589000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1007493"}},"subtitle":[],"editor":[{"given":"Jasmine","family":"Foo","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2019,11,18]]},"references-count":49,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,11,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1007493","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pcbi.1007493","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,18]]}}}